Leerink Partnrs Reduces Earnings Estimates for Owens & Minor

Owens & Minor, Inc. (NYSE:OMI) – Stock analysts at Leerink Partnrs decreased their FY2026 earnings estimates for Owens & Minor in a report released on Thursday, February 20th. Leerink Partnrs analyst M. Cherny now forecasts that the company will earn $1.95 per share for the year, down from their prior estimate of $1.97. The consensus estimate for Owens & Minor’s current full-year earnings is $1.51 per share. Leerink Partnrs also issued estimates for Owens & Minor’s FY2027 earnings at $2.33 EPS.

A number of other equities analysts have also recently weighed in on the stock. UBS Group reduced their price objective on shares of Owens & Minor from $25.00 to $13.00 and set a “buy” rating for the company in a research report on Thursday, February 13th. Citigroup reduced their price objective on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating for the company in a research report on Tuesday, November 5th. Barclays reduced their price objective on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating for the company in a research report on Tuesday, November 5th. Finally, Robert W. Baird reduced their price objective on shares of Owens & Minor from $15.00 to $14.00 and set a “neutral” rating for the company in a research report on Tuesday, February 4th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $16.79.

Owens & Minor Stock Performance

NYSE:OMI opened at $6.23 on Friday. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09. The company has a fifty day moving average of $12.06 and a two-hundred day moving average of $13.52. The stock has a market capitalization of $480.01 million, a PE ratio of -9.58, a P/E/G ratio of 0.20 and a beta of 0.48. Owens & Minor has a fifty-two week low of $6.07 and a fifty-two week high of $28.35.

Institutional Investors Weigh In On Owens & Minor

A number of large investors have recently modified their holdings of the business. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Owens & Minor by 29.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 219,761 shares of the company’s stock worth $2,872,000 after buying an additional 50,184 shares in the last quarter. Voloridge Investment Management LLC grew its holdings in shares of Owens & Minor by 24.2% in the fourth quarter. Voloridge Investment Management LLC now owns 243,525 shares of the company’s stock valued at $3,183,000 after purchasing an additional 47,459 shares during the period. Squarepoint Ops LLC purchased a new stake in shares of Owens & Minor in the fourth quarter valued at about $381,000. State of Wyoming grew its holdings in shares of Owens & Minor by 35.3% in the fourth quarter. State of Wyoming now owns 23,198 shares of the company’s stock valued at $303,000 after purchasing an additional 6,050 shares during the period. Finally, ProShare Advisors LLC grew its holdings in shares of Owens & Minor by 44.5% in the fourth quarter. ProShare Advisors LLC now owns 22,702 shares of the company’s stock valued at $297,000 after purchasing an additional 6,996 shares during the period. Hedge funds and other institutional investors own 98.04% of the company’s stock.

About Owens & Minor

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.